Ryan Neal, MD
Hospitalist · Houston, TXNPI 1710936273
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $147,138 of the $154,330 with a category attached, or 95.3%. Amgen accounts for 99.7% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2023 at $67,598 and has fallen 93.9% since, to $4,092 in 2025. Among hospitalist clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 163 payments — averaging $946.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$154K
- Impulse Dynamics (USA) Inc.$179
- Astellas Pharma US Inc$80
- Merck$54
- Boston Scientific$23
- Melinta Therapeutics, LLC$18
- plus $32 from 2 others
What the payments were for
- Speaking & faculty fees$147,13895%
- Travel & lodging$2,6622%
- Food & beverage$4,4033%
- Education$1270%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 153 | $153,944 |
| Impulse Dynamics (USA) Inc. | 1 | $179 |
| Astellas Pharma US Inc | 1 | $80 |
| Merck | 4 | $54 |
| Boston Scientific | 1 | $23 |
| Melinta Therapeutics, LLC | 1 | $18 |
| Pfizer | 1 | $16 |
| Nabriva Therapeutics, PLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$154,330 in reported general payments places this provider in the 95th percentile of 1,284 hospitalist providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other hospitalist in Houston
- Ahmad BaroutHouston$44K
- Laxman KalvakuntlaHouston$30K
- Joshua HahnHouston$23K
- Grace OdiHouston$14K
- Spencer SuHouston$9K
- Martin Chacon PortilloHouston$9K
- Abeer SiddiqiHouston$9K
- Brent GudenkaufHouston$8K
- Dilpreet SinghHouston$7K
- John FlynnHouston$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.